EUVIMEDEUVIMED entdecken
Evaluationsstudie

Rapid tests should be used with caution for HIV-1 primary infection screening

Vincent Guiraud, Quentin Beaulieu, Antoine Fauchois, Pascale Jean-Charles, Marie-Capucine Costes, Bruno Le Labousse, Pr Agnès Gautheret-Dejean

Medical Microbiology and Immunology · 2024

DOI: 10.1007/s00430-024-00792-1 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Medical Microbiology and Immunology, 2024. Verfasst von Vincent Guiraud und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France. Hauptthemen laut MEDLINE: HIV Infections, Sensitivity and Specificity, HIV-1, Mass Screening. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid tests allow outpatient, low cost, reliable, screening for chronic HIV infection. However, data regarding their sensitivity on primary infection remain scarce. The objective of this study was to assess sensitivity of nine HIV rapid tests for primary HIV-1 infection screening. Seventy-five serum samples from patients during HIV-1 primary infection were included. Primary infection was diagnosed by a positive 4th generation ELISA and HIV-1 RNA positivity confirmed by Western blot patterns associated with HIV-1 primary infection. Early seroconversion was defined as the absence of antibodies on HIV-1 Western blot associated with HIV-1 RNA and p24-antigen positivity. An identical sensitivity (95% CI) of 76.7% (65.2-84.2%) was observed for HIV 1/2 STAT-PAK® Assay (STAT-PAK), INSTI™ HIV-1/HIV-2 antibody Test (INSTI), SURE CHECK® HIV 1/2 (SURE CHECK) and MULTISURE HIV rapid test (MULTISURE) with visual reading. Sensitivity was 74.7% (63.8-83.1%) for MULTISURE (automatic reading), 77.0% (66.3-85.1%) for FIRST RESPONSE® Test VIH 1-2.O CARTE (FIRST RESPONSE), 83.8% (73.8-90.5%) for VIKIA HIV1/2® (VIKIA), 88.0% (78.7-93.6%) for Genie™ Fast HIV 1/2 (Genie Fast), 88.6% (79.0-94.1%) for Hexagon HIV (Hexagon), and 92.8% (83.6-96.3%) for Exacto® TEST HIV Pro (Exacto). However, rapid tests performed poorly for the early seroconversion subgroup (n = 14), with sensitivities ranging from 7% (1.3-31.5%) for STAT-PAK, INSTI, SURE CHECK, MULTISURE (automatic reading), to 29% (12-55%) for FIRST RESPONSE, 31% (13-58%) for VIKIA, 43% (21-67%) for Hexagon and 57.1% (32.6-78.6%) for Exacto and Genie Fast. Overall, despite significant discrepancies in sensitivity, HIV rapid tests should be used with caution in the context of a suspected primary infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsSensitivity and SpecificityHIV-1Mass ScreeningHIV AntibodiesHumansMaleFemaleAdultMiddle AgedRNA, ViralEnzyme-Linked Immunosorbent AssayYoung AdultBlotting, WesternDiagnostic Tests, RoutineHIV Testing

Stichwörter der Autor:innen

HIV-1Primary infectionRapid testScreeningSensitivitySeroconversion

Substanzen

HIV AntibodiesRNA, Viral

Autor:innen und Institutionen

  • Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France.
  • Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France. agnes.gautheret@aphp.fr.
  • Université Paris cité, INSERM UMR-S 1139 Physiopathologie et pharmacotoxicologie placentaire humaine : microbiote pré & post-natal, Paris, F-75006, France. agnes.gautheret@aphp.fr.

Zitieren

APA

Guiraud, V., Beaulieu, Q., Fauchois, A., Jean-Charles, P., Costes, M. C., Labousse, B. L., & Gautheret-Dejean, P. A. (2024). Rapid tests should be used with caution for HIV-1 primary infection screening. Medical Microbiology and Immunology. https://doi.org/10.1007/s00430-024-00792-1

Vancouver

Guiraud V, Beaulieu Q, Fauchois A, Jean-Charles P, Costes MC, Labousse BL, et al. Rapid tests should be used with caution for HIV-1 primary infection screening. Medical Microbiology and Immunology. 2024. doi:10.1007/s00430-024-00792-1

BibTeX
@article{Guiraud2024,
  author = {Guiraud, Vincent and Beaulieu, Quentin and Fauchois, Antoine and Jean-Charles, Pascale and Costes, Marie-Capucine and Labousse, Bruno Le and Gautheret-Dejean, Pr Agnès},
  title = {Rapid tests should be used with caution for HIV-1 primary infection screening},
  journal = {Medical Microbiology and Immunology},
  year = {2024},
  doi = {10.1007/s00430-024-00792-1}
}
Kostenlos starten →